Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) | Polymerase basic protein 2 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | Get druggable targets OG5_158196 | All targets in OG5_158196 |
Trichomonas vaginalis | conserved hypothetical protein | Get druggable targets OG5_158196 | All targets in OG5_158196 |
Trichomonas vaginalis | conserved hypothetical protein | Get druggable targets OG5_158196 | All targets in OG5_158196 |
Trichomonas vaginalis | conserved hypothetical protein | Get druggable targets OG5_158196 | All targets in OG5_158196 |
Trichomonas vaginalis | conserved hypothetical protein | Get druggable targets OG5_158196 | All targets in OG5_158196 |
Trichomonas vaginalis | conserved hypothetical protein | Get druggable targets OG5_158196 | All targets in OG5_158196 |
Trichomonas vaginalis | hypothetical protein | Get druggable targets OG5_158196 | All targets in OG5_158196 |
Trichomonas vaginalis | conserved hypothetical protein | Get druggable targets OG5_158196 | All targets in OG5_158196 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0259 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0259 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0371 | 0.0869 |
Entamoeba histolytica | protein kinase, putative | 0.0116 | 0.4264 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0259 | 1 | 1 |
Echinococcus multilocularis | glycogen synthase kinase 3 beta | 0.0116 | 0.4264 | 1 |
Schistosoma mansoni | nephrin | 0.0019 | 0.0371 | 0.0869 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0116 | 0.4264 | 1 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0116 | 0.4264 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0371 | 0.0869 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0371 | 0.0869 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0022 | 0.0507 | 0.1188 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0116 | 0.4264 | 1 |
Echinococcus granulosus | roundabout 2 | 0.0019 | 0.0371 | 0.0869 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0259 | 1 | 1 |
Echinococcus multilocularis | neuroglian | 0.0019 | 0.0371 | 0.0869 |
Schistosoma mansoni | defective proboscis extension response (dpr)-related | 0.0019 | 0.0371 | 0.0869 |
Echinococcus granulosus | glycogen synthase kinase 3 beta | 0.0116 | 0.4264 | 1 |
Echinococcus multilocularis | Immunoglobulin | 0.0019 | 0.0371 | 0.0869 |
Giardia lamblia | Kinase, CMGC GSK | 0.0116 | 0.4264 | 0.5 |
Echinococcus granulosus | Immunoglobulin | 0.0019 | 0.0371 | 0.0869 |
Schistosoma mansoni | glycogen synthase kinase 3-related (gsk3) (cmgc group III) | 0.0116 | 0.4264 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0371 | 0.0869 |
Echinococcus multilocularis | Immunoglobulin | 0.0019 | 0.0371 | 0.0869 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0259 | 1 | 1 |
Echinococcus granulosus | tyrosine protein kinase Lyn | 0.0011 | 0.0045 | 0.0104 |
Brugia malayi | intracellular kinase | 0.0116 | 0.4264 | 1 |
Toxoplasma gondii | cell-cycle-associated protein kinase GSK, putative | 0.0116 | 0.4264 | 0.5 |
Plasmodium vivax | glycogen synthase kinase 3, putative | 0.0116 | 0.4264 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0371 | 0.0869 |
Echinococcus granulosus | neurotracting:lsamp:neurotrimin:obcam | 0.0019 | 0.0371 | 0.0869 |
Trichomonas vaginalis | hypothetical protein | 0.0259 | 1 | 1 |
Echinococcus multilocularis | basement membrane specific heparan sulfate | 0.0019 | 0.0371 | 0.0869 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0371 | 0.0869 |
Echinococcus granulosus | neuroglian | 0.0019 | 0.0371 | 0.0869 |
Trypanosoma cruzi | glycogen synthase kinase 3, putative | 0.0116 | 0.4264 | 0.5 |
Echinococcus multilocularis | roundabout 2 | 0.0019 | 0.0371 | 0.0869 |
Leishmania major | glycogen synthase kinase, putative;with=GeneDB:LinJ18_V3.0270 | 0.0116 | 0.4264 | 0.5 |
Schistosoma mansoni | vesicular amine transporter | 0.0019 | 0.0371 | 0.0869 |
Echinococcus granulosus | twitchin | 0.002 | 0.0415 | 0.0973 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0116 | 0.4264 | 1 |
Loa Loa (eye worm) | TK/KIN16 protein kinase | 0.0022 | 0.0507 | 0.1188 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0371 | 0.0869 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0371 | 0.0869 |
Echinococcus granulosus | protein kinase shaggy | 0.0116 | 0.4264 | 1 |
Trypanosoma brucei | protein kinase, putative | 0.0116 | 0.4264 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0259 | 1 | 1 |
Schistosoma mansoni | Neurotrimin precursor (hNT) | 0.0019 | 0.0371 | 0.0869 |
Echinococcus multilocularis | protein kinase shaggy | 0.0116 | 0.4264 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0371 | 0.0869 |
Brugia malayi | Fibronectin type III domain containing protein | 0.0019 | 0.0371 | 0.0869 |
Onchocerca volvulus | 0.0116 | 0.4264 | 1 | |
Plasmodium falciparum | glycogen synthase kinase 3 | 0.0116 | 0.4264 | 0.5 |
Giardia lamblia | Kinase, CMGC GSK | 0.0116 | 0.4264 | 0.5 |
Brugia malayi | Immunoglobulin I-set domain containing protein | 0.0019 | 0.0371 | 0.0869 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0371 | 0.0869 |
Schistosoma mansoni | cell adhesion molecule | 0.0019 | 0.0371 | 0.0869 |
Echinococcus granulosus | defective proboscis extension response | 0.0019 | 0.0371 | 0.0869 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Kd (binding) | < 0.002 uM | Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assay | ChEMBL. | 25019388 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.